financetom
Business
financetom
/
Business
/
StandardAero Prices Upsized IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
StandardAero Prices Upsized IPO
Oct 2, 2024 10:46 PM

04:23 AM EDT, 10/02/2024 (MT Newswires) -- StandardAero ( SARO ) said late Tuesday it priced its initial public offering of 60 million common shares at $24 per share, upsized from 46.5 million shares.

The aerospace services provider previously disclosed an indicative price range of $20 to $23 per share.

The IPO includes about 53.3 million shares to be issued and sold by StandardAero ( SARO ) and about 6.8 million shares to be sold by existing stockholders.

The selling stockholders have granted the underwriters a 30-day option to buy up to 9 million additional shares.

The shares are expected to start trading on the New York Stock Exchange under the symbol "SARO" on Wednesday. The offering is expected to close Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
On Holding Swings to Q4 Adjusted Loss, Net Sales Increase
On Holding Swings to Q4 Adjusted Loss, Net Sales Increase
Mar 12, 2024
07:13 AM EDT, 03/12/2024 (MT Newswires) -- On Holding ( ONON ) reported a Q4 adjusted diluted loss Tuesday of 0.05 Swiss franc ($0.06) per class A share, swinging from an adjusted EPS of 0.02 franc a year earlier. Analysts polled by Capital IQ expected 0.13 franc in adjusted EPS. Net sales for the quarter ended Dec. 21 were 447.1...
ADM misses quarterly profit estimates
ADM misses quarterly profit estimates
Mar 12, 2024
March 12 (Reuters) - Archer-Daniels-Midland ( ADM ) reported lower-than-expected fourth-quarter earnings on Tuesday, after an investigation into accounting practices at the company's nutrition unit delayed the release of its financial results for nearly two months. The global grains merchant reported adjusted earnings of $1.36 per share for the fourth quarter, while analysts had expected earnings of $1.43 per share,...
Pfizer's drug succeeds in late-stage blood cancer trial
Pfizer's drug succeeds in late-stage blood cancer trial
Mar 12, 2024
March 12 (Reuters) - Pfizer ( PFE ) said on Tuesday a combination treatment using its drug, Adcetris, met the main goal of a late-stage study of extending survival in patients with a type of blood cancer. The combination therapy consisting of Adcetris and two other drugs was statistically significant compared to a placebo in extending survival in patients with...
Kohl's forecasts weaker annual profit on higher spending
Kohl's forecasts weaker annual profit on higher spending
Mar 12, 2024
(Reuters) -Kohl's on Tuesday forecast fiscal 2024 profit below market expectations, as it aims to spend on expanding its Sephora partnership and other investment activities. The retailer forecast annual earnings per share in the range of $2.10 to $2.70, the mid-point of which was below analysts' average estimate of $2.61, as per LSEG data. Kohl's anticipates a potential impact from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved